6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine

C111H110Br4IN37O — CID 158615906

About 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine

6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine (PubChem CID 158615906) has the molecular formula C111H110Br4IN37O and a molecular weight of 2424.88 g/mol. Its IUPAC name is 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine.

Molecular Properties

• Compound Name: 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine
• PubChem CID: 158615906
• Molecular Formula: C111H110Br4IN37O
• Molecular Weight: 2424.88 g/mol
• Exact Mass: 2419.55
• IUPAC Name: 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine
• SMILES: CN(C)c1cccc(Nc2nc(Br)cn3c(-c4cccnc4)cnc23)c1.CN(C)c1cccc(Nc2nc(Br)cn3c(I)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(-c4cccc(C(N)=O)c4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(Br)cnc23)c1.CNc1nc(Br)cn2c(-c3ccc(N(C)C)cc3)cnc12.Cc1cnc2c(NCc3ccccn3)nccn12.Cc1cnc2c(Nc3cccc(N(C)C)c3)nccn12
• InChI: InChI=1S/C21H20N6O.C19H17BrN6.C15H16BrN5.C15H17N5.C14H13BrIN5.C14H14BrN5.C13H13N5/c1-26(2)17-8-4-7-16(12-17)25-20-21-24-13-18(27(21)10-9-23-20)14-5-3-6-15(11-14)19(22)28;1-25(2)15-7-3-6-14(9-15)23-18-19-22-11-16(13-5-4-8-21-10-13)26(19)12-17(20)24-18;1-17-14-15-18-8-12(21(15)9-13(16)19-14)10-4-6-11(7-5-10)20(2)3;1-11-10-17-15-14(16-7-8-20(11)15)18-12-5-4-6-13(9-12)19(2)3;1-20(2)10-5-3-4-9(6-10)18-13-14-17-7-12(16)21(14)8-11(15)19-13;1-19(2)11-5-3-4-10(8-11)18-13-14-17-9-12(15)20(14)7-6-16-13;1-10-8-17-13-12(15-6-7-18(10)13)16-9-11-4-2-3-5-14-11/h3-13H,1-2H3,(H2,22,28)(H,23,25);3-12H,1-2H3,(H,23,24);4-9H,1-3H3,(H,17,19);4-10H,1-3H3,(H,16,18);3-8H,1-2H3,(H,18,19);3-9H,1-2H3,(H,16,18);2-8H,9H2,1H3,(H,15,16)
• InChIKey: HXJOXSUAXQNIEL-UHFFFAOYSA-N
• XLogP: 23.03
• TPSA: 383.85 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 37
• Rotatable Bonds: 24
• Heavy Atoms: 154
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2424.88
LogP ≤ 5	23.03
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	37

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'iodine', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine?

The IUPAC name of 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine (CID 158615906) is 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine.

What is the SMILES notation for 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine?

The canonical SMILES for 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine is CN(C)c1cccc(Nc2nc(Br)cn3c(-c4cccnc4)cnc23)c1.CN(C)c1cccc(Nc2nc(Br)cn3c(I)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(-c4cccc(C(N)=O)c4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(Br)cnc23)c1.CNc1nc(Br)cn2c(-c3ccc(N(C)C)cc3)cnc12.Cc1cnc2c(NCc3ccccn3)nccn12.Cc1cnc2c(Nc3cccc(N(C)C)c3)nccn12.

What is the InChIKey of 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine?

The InChIKey is HXJOXSUAXQNIEL-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20N6O.C19H17BrN6.C15H16BrN5.C15H17N5.C14H13BrIN5.C14H14BrN5.C13H13N5/c1-26(2)17-8-4-7-16(12-17)25-20-21-24-13-18(27(21)10-9-23-20)14-5-3-6-15(11-14)19(22)28;1-25(2)15-7-3-6-14(9-15)23-18-19-22-11-16(13-5-4-8-21-10-13)26(19)12-17(20)24-18;1-17-14-15-18-8-12(21(15)9-13(16)19-14)10-4-6-11(7-5-10)20(2)3;1-11-10-17-15-14(16-7-8-20(11)15)18-12-5-4-6-13(9-12)19(2)3;1-20(2)10-5-3-4-9(6-10)18-13-14-17-7-12(16)21(14)8-11(15)19-13;1-19(2)11-5-3-4-10(8-11)18-13-14-17-9-12(15)20(14)7-6-16-13;1-10-8-17-13-12(15-6-7-18(10)13)16-9-11-4-2-3-5-14-11/h3-13H,1-2H3,(H2,22,28)(H,23,25);3-12H,1-2H3,(H,23,24);4-9H,1-3H3,(H,17,19);4-10H,1-3H3,(H,16,18);3-8H,1-2H3,(H,18,19);3-9H,1-2H3,(H,16,18);2-8H,9H2,1H3,(H,15,16).

What are the key properties of 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine?

6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine has a molecular weight of 2424.88 g/mol, XLogP of 23.03, 24 rotatable bonds, 8 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for 6-bromo-3-[4-(dimethylamino)phenyl]-N-methylimidazo[1,2-a]pyrazin-8-amine;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-iodoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;3-methyl-N-(pyridin-2-ylmethyl)imidazo[1,2-a]pyrazin-8-amine is sourced from PubChem (CID 158615906), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).